Lacrimedics, Inc. was founded in 1984 by Ophthalmologist, Robert S. Herrick, M.D., a specialist in corneal and external diseases since the 1970s. Dr. Herrick has developed many innovative products and procedures used in the care of patients with Dry Eye Disease (DED) and Lacrimal System Dysfunction (LSD).
The company's proprietary products include the Dissolvable VisiPlug Lacrimal Plug that provides medium-term Occlusion Therapy lasting approximately 180 days and the OPAQUE Herrick Lacrimal Plug for long-term Occlusion Therapy.
Lacrimedics pioneered the development of the Collagen Plugs for the Lacrimal Efficiency Test in the early 1980s. This revolutionary product provides a simple and cost-effective method to diagnose Dry Eye Disease and determine if the patient will respond favorably to Occlusion Therapy.
Lacrimedics designs, develops, and manufactures occlusion therapy devices for the treatment of Dry Eye Disease and underlying symptoms.
Lacrimedics' devices are intended for sale to and use by licensed healthcare professionals and are marketed throughout the world.
Lacrimedics is committed to providing its customers with high quality, efficiently produced products at a fair price while meeting its customers’ expectations in terms of quality, delivery, and value.
Robert S. Herrick, II
Brian P. Logan
Chief Operating Officer
Sr. Director of Strategic Relationships
Director of Information Resources
Manager, Client Relationships